Cybin Inc. (CYBN)
CYBN Stock Price Chart
Explore Cybin Inc. interactive price chart. Choose custom timeframes to analyze CYBN price movements and trends.
CYBN Company Profile
Discover essential business fundamentals and corporate details for Cybin Inc. (CYBN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Sept 2019
Employees
50.00
Website
https://www.cybin.comCEO
Douglas L. Drysdale
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
CYBN Financial Timeline
Browse a chronological timeline of Cybin Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 Aug 2025
EPS came in at -$1.10 falling short of the estimated -$0.51 by -115.69%.
Earnings released on 1 Jul 2025
EPS came in at -$1.46 falling short of the estimated -$1.18 by -23.73%.
Earnings released on 10 Feb 2025
EPS came in at -$0.38 surpassing the estimated -$0.51 by +25.49%.
Earnings released on 13 Nov 2024
EPS came in at -$2.10 falling short of the estimated -$0.38 by -452.63%.
Stock split effective on 19 Sept 2024
Shares were split 1 : 38 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Aug 2024
EPS came in at -$0.38 falling short of the estimated -$0.02 by -1.80K%.
Earnings released on 26 Jun 2024
EPS came in at -$1.52 falling short of the estimated -$0.76 by -100.00%.
Earnings released on 14 Feb 2024
EPS came in at -$2.66 falling short of the estimated -$1.14 by -133.33%.
Earnings released on 14 Nov 2023
EPS came in at -$1.52 surpassing the estimated -$1.90 by +20.00%.
Earnings released on 14 Aug 2023
EPS came in at -$1.90 matching the estimated -$1.90.
Earnings released on 27 Jun 2023
EPS came in at -$1.90 matching the estimated -$1.90.
Earnings released on 14 Feb 2023
EPS came in at -$1.52 surpassing the estimated -$2.28 by +33.33%.
Earnings released on 14 Nov 2022
EPS came in at -$1.90 surpassing the estimated -$2.28 by +16.67%.
Earnings released on 8 Aug 2022
EPS came in at -$2.28 surpassing the estimated -$3.04 by +25.00%.
Earnings released on 22 Jun 2022
EPS came in at -$3.04 falling short of the estimated -$2.66 by -14.29%.
Earnings released on 10 Feb 2022
EPS came in at -$3.04 surpassing the estimated -$3.42 by +11.11%.
Earnings released on 15 Nov 2021
EPS came in at -$3.42 falling short of the estimated -$2.66 by -28.57%.
Earnings released on 13 Aug 2021
EPS came in at -$2.66 falling short of the estimated -$1.90 by -40.00%.
Earnings released on 28 Jun 2021
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%, while revenue for the quarter reached -$109.79 .
Earnings released on 16 Feb 2021
EPS came in at -$0.10 falling short of the estimated -$0.03 by -233.33%.
Earnings released on 1 Dec 2020
EPS came in at -$0.00 .
Earnings released on 10 Nov 2020
EPS came in at -$2.01 , while revenue for the quarter reached $636.84K .
Stock split effective on 10 Nov 2020
Shares were split 149 : 1000 , changing the number of shares outstanding and the price per share accordingly.
CYBN Stock Performance
Access detailed CYBN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.